Krystal Biotech EPS - Earnings per Share 2017-2024 | KRYS

Krystal Biotech earnings per share (EPS) for the twelve months ending September 30, 2024 was $2.08, a 243.45% decline year-over-year.

  • Krystal Biotech EPS for the quarter ending September 30, 2024 was $0.91, a 67.38% decline year-over-year.
  • Krystal Biotech 2023 annual EPS was $0.39, a 107.1% decline from 2022.
  • Krystal Biotech 2022 annual EPS was $-5.49, a 75.4% increase from 2021.
  • Krystal Biotech 2021 annual EPS was $-3.13, a 83.04% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Krystal Biotech EPS - Earnings per Share 2017-2024 | KRYS

  • Krystal Biotech EPS for the quarter ending September 30, 2024 was $0.91, a 67.38% decline year-over-year.
  • Krystal Biotech 2023 annual EPS was $0.39, a 107.1% decline from 2022.
  • Krystal Biotech 2022 annual EPS was $-5.49, a 75.4% increase from 2021.
  • Krystal Biotech 2021 annual EPS was $-3.13, a 83.04% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.